or Try an Advanced Search...

    ETF Components for FBT - First Trust Amex Biotech Index Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL B 2.24 4.51
    CORT B 2.90 4.07
    INCY C 1.89 3.97
    NTRA B -1.24 3.92
    ITCI C 0.28 3.90
    ACAD D 1.17 3.85
    ARGX A 1.54 3.74
    GILD C 0.48 3.66
    UTHR C 1.51 3.64
    CPRX C 1.70 3.62
    NBIX C 0.52 3.59
    WAT B 1.35 3.55
    RGEN D 0.58 3.46
    HALO F 7.22 3.44
    VRTX F 0.13 3.39
    ALKS B 3.90 3.31
    ILMN D 2.30 3.30
    BMRN D 1.28 3.15
    ALNY D -0.77 3.06
    GMAB F 0.88 3.04
    AMGN D 1.60 3.04
    SRPT D 3.38 2.96
    BIIB F -0.07 2.95
    BNTX D 4.53 2.90
    MTD D 1.77 2.88
    BRKR D 1.51 2.85
    BGNE D -2.08 2.76
    REGN F -0.87 2.60
    EXAS D -0.30 2.42
    MRNA F 7.48 2.30

    Represented by ETF Holdings

    Keywords: Biotechnology Biopharmaceutical Medicine S&P 500 Nasdaq 100 Cancer Life Sciences Disorders Inflammation Monoclonal Antibodies Monoclonal Antibody Biology Chemical Compounds Clinical Development Clinical Research Diabetes Immunology Infectious Diseases Lymphoma Pain
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities

    Recent News for First Trust Amex Biotech Index Fund & its Holdings

    Date Stock Title
    Nov 23 INCY What Moved Markets This Week
    Nov 23 VRTX 3 Monster Stocks in the Making
    Nov 22 MRNA Jefferies says market nears short term “peak RFK negativity", Vaccine makers up
    Nov 22 MRNA Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
    Nov 22 MRNA Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
    Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
    Nov 22 MRNA Moderna up 8% as Jefferies says market is close to 'peak RFK negativity'
    Nov 22 HALO Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
    Nov 22 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
    Nov 22 CORT Corcept Shares Rise More Than 60% in Three Months: Here's Why
    Nov 22 MRNA Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store
    Nov 22 HALO Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
    Nov 22 AMGN Why Amgen (AMGN) is a Top Value Stock for the Long-Term
    Nov 22 HALO Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal
    Nov 22 HALO Halozyme withdraws $2.1 billion buyout offer for Evotec
    Nov 22 HALO Halozyme gains after withdrawing Evotec bid
    Nov 22 HALO Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
    Nov 22 AMGN RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
    Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
    Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index Biotechnology
    Back to the Main FBT Page...